• Should I Skip My GLP-1 for the Holidays?
    Nov 16 2026

    Should I Skip My GLP-1 for the Holidays?

    The holidays are here, and for people taking GLP-1 medications like Wegovy, Zepbound, or Ozempic, that can bring up a question: Should I skip my GLP-1 so I can enjoy holiday meals?

    In this special crossover episode of Weight & Measure with Mike and Zach and Your GLP-1 Bestie, Mike is joined by registered dietitian, certified personal trainer, and author Gianna Beasley to talk about navigating the holiday season while taking obesity management medications (OMMs).

    From Thanksgiving dinner and family gatherings to changing appetites, food noise, and gastrointestinal side effects, Mike and Gianna explore what it means to enjoy the holidays when your relationship with food may look different than it once did.

    And perhaps most importantly, they challenge the idea that enjoying the holidays requires putting your health goals or treatment on hold.

    • Should you skip your GLP-1 for the holidays? Why some people consider delaying or skipping doses around holiday meals and the importance of discussing medication changes with your prescriber.

    • Managing GLP-1 side effects: Practical considerations for navigating nausea, fullness, and digestive discomfort when traditional holiday foods are on the menu.

    • Holiday eating without guilt: How to enjoy your favorite foods, honor your appetite, and move away from all-or-nothing thinking.

    • Food noise and changing traditions: How GLP-1 medications can reshape the way we experience food-centered celebrations.

    • Navigating family gatherings: Handling unwanted comments, food pressure, and conversations about your body or medication.

    • Building healthier holiday traditions: Finding joy in the season beyond what's on your plate.

    Mike and Gianna also share their personal experiences with holiday traditions, favorite foods, and the freedom that can come from changing your relationship with food.

    We're excited to announce our partnership with The Obesity Society for From Discovery to Impact: What Patients Measure, a special series connecting the latest obesity research with the experiences and priorities of people living with obesity.

    We'll bring conversations from ObesityWeek with researchers, clinicians, and patient advocates about emerging treatments, metabolic health, food noise, and what the science means for patients.

    Gianna Beasley, RDN, CPT

    • Podcast: Your GLP-1 Bestie

    • Instagram: @dietitian.gianna

    • Book: The GLP-1 Solution

    Obesity science doesn't have to be complicated, and nobody should have to navigate it alone.

    If you enjoyed this conversation, follow Weight & Measure on your favorite podcast platform, subscribe to our YouTube channel, and share this episode with someone navigating the holidays while taking a GLP-1 medication.

    Website: https://weightandmeasurepod.com

    YouTube: https://www.youtube.com/@WeightandMeasurePodcast

    Weight & Measure — Obesity science translated for the people living it.

    More science. Less stigma.

    Disclaimer: This podcast is intended for educational and informational purposes only and is not a substitute for individualized medical advice. Always consult your prescribing healthcare professional before changing your medication schedule.

    Show More Show Less
    47 mins
  • Do GLP-1s Cause Muscle Loss? Tirzepatide vs. Semaglutide | Research Round Up 11.13.2026
    Nov 13 2026

    Do GLP-1 medications cause muscle loss? And why can two people taking the same obesity medication have very different results?

    In the first Weight & Measure Research Roundup, Zach breaks down three new papers in under 14 minutes. We start with a study comparing tirzepatide and semaglutide: the difference in lean mass loss narrowed from 2.1 to 0.1 percentage points after researchers accounted for total weight lost. Zach explains what a body composition scan can tell us, why lean mass and skeletal muscle are different, and why strength and physical function belong in the conversation.

    We also look at whether rare genetic variants might help explain differences in semaglutide response, and what a map of 517 GLP-1 trials leaves unanswered about using Obesity Management Medications (OMMs) before or after metabolic & bariatric surgery.

    Chapters

    00:00 Welcome to the Research Roundup
    01:32 GLP-1 muscle loss headlines: What did the study measure?
    04:57 Could genetics influence semaglutide response?
    08:24 What 517 GLP-1 trials tell us about medication and surgery
    11:24 What should we measure beyond weight loss?

    Studies discussed

    • Tirzepatide vs. semaglutide and lean mass in routine care — npj Exercise Medicine and Health

    • Rare GLP1R variants and response to semaglutide or tirzepatide — Nature Metabolism

    • A systematic evidence map of 517 GLP-1 clinical trials — Obesity Surgery

    Would you like more short research episodes between our regular conversations? Tell us what question you’d like us to cover next. Follow Weight & Measure wherever you listen, subscribe on YouTube, and read the weekly Research Roundup.

    More science. Less stigma.

    Show More Show Less
    13 mins
  • FNCE 2026: GLP-1s, Protein Hype & What Dietitians Want You to Know
    Nov 9 2026

    GLP-1 medications are transforming nutrition care, protein is being added to everything, and nutrition misinformation continues to challenge patients and practitioners. So what did we learn at FNCE 2026?

    In this special episode of Weight & Measure with Mike and Zach, we're sharing our reactions and biggest takeaways from the Academy of Nutrition and Dietetics' Food & Nutrition Conference & Expo (FNCE) 2026 in San Antonio.

    We discuss the growing challenge of nutrition misinformation, the importance of compassionate childhood obesity care, and why metabolic dysfunction-associated steatotic liver disease (MASLD) deserves greater attention.

    We also explore health equity in GLP-1 and diabetes treatment, the food industry's obsession with protein, the growing conversation around fiber, and the challenges of maintaining adequate nutrition, muscle, and physical performance while taking obesity management medications.

    Along the way, we reflect on our experiences at the conference, the evolving role of registered dietitians, and how our own experiences with nutrition counseling shape the way we view obesity care today.

    Our biggest takeaway? Better obesity care requires more than medications or weight loss. It requires evidence-based nutrition guidance, individualized support, and healthcare professionals who understand the people they're treating.

    Join us for a candid conversation about what caught our attention, what surprised us, and what we hope patients and practitioners take away from FNCE 2026.

    More Science. Less Stigma.

    Explore more and subscribe: https://weightandmeasurepod.com

    Show More Show Less
    33 mins
  • Do You Have to Stay on GLP-1s Forever?
    Nov 2 2026

    Do You Have to Stay on GLP-1s Forever?

    Guests: Ana Reisdorf, MS, RD & Melissa Mitri, MS, RD

    Can you stop taking GLP-1 medications and maintain your weight loss? What happens when hunger and food noise return? And is staying on treatment long-term really necessary?

    In this special episode from our FNCE 2026 coverage, Mike and Zach sit down with registered dietitians Ana Reisdorf and Melissa Mitri to explore one of the most common questions in obesity medicine: Do you have to stay on GLP-1 medications forever?

    Ana shares her own experiences stopping and restarting GLP-1 treatment, including how those experiences challenged her professional assumptions about weight management. Melissa offers insights from her work with patients navigating long-term treatment, medication interruptions, and sustainable nutrition habits.

    Together, they discuss what current research tells us about discontinuation, where evidence for tapering and maintenance dosing remains limited, and why weight reoccurrence should never be treated as a personal failure.

    Topics include:

    • What research tells us about stopping GLP-1 medications

    • The science and uncertainty surrounding tapering and maintenance doses

    • Hunger, food noise, and appetite after discontinuation

    • Why healthy habits don't necessarily replace chronic disease treatment

    • Nutrition, protein, physical activity, and muscle health

    • The psychological transition from active weight loss to maintenance

    • Weight reoccurrence, medication restarts, and removing shame

    • Making individualized treatment decisions with your healthcare team

    The central takeaway: Long-term obesity treatment is not about proving you can manage without medication. It's about finding the tools and care that support your health over time.

    Website: https://weightandmeasurepod.com

    YouTube: https://www.youtube.com/@WeightandMeasurePodcast

    More science. Less stigma.

    This podcast is for educational purposes and does not replace individualized medical advice.

    Show More Show Less
    46 mins
  • GLP-1 Weight Loss: Are We Measuring Success All Wrong?
    Oct 27 2026

    Are GLP-1 medications like Ozempic, Wegovy, and Zepbound changing how we define successful weight loss? And is the number on the scale telling us the whole story?

    What about muscle loss, strength, physical activity, long-term health, and access to obesity treatment?

    In this special episode of Weight & Measure with Mike and Zach, recorded in connection with FNCE 2026, we sit down with three experts to explore a fundamental question: Are we measuring GLP-1 success the wrong way?

    Joining us:

    Dr. Angela Fitch, Founder and Chief Medical Officer of knownwell, discusses what successful obesity treatment should look like beyond pounds lost and why individualized, long-term care matters.

    Dr. John Jakicic, Professor at the University of Kansas Medical Center, breaks down the science of GLP-1 medications, lean mass, muscle loss, strength, and exercise.

    Dr. Tracy Zvenyach, Vice President of Advocacy & Research at the Obesity Action Coalition, explores the barriers patients face in accessing treatment, including insurance coverage, affordability, Medicare, Medicaid, and obesity care policy.

    • Are we too focused on weight loss when measuring GLP-1 treatment success?

    • What's the difference between losing lean mass, muscle mass, and strength?

    • Do GLP-1 medications cause muscle loss, and what should patients understand about the research?

    • How can resistance training and physical activity support health during obesity treatment?

    • What improvements should patients look for beyond the number on the scale?

    • Why do people with similar medical needs have different access to GLP-1 medications?

    • What could Medicare coverage changes and the Treat and Reduce Obesity Act mean for patients?

    • How can patients advocate for better access to comprehensive obesity care?

    The bigger question: If successful obesity treatment is about improving health and quality of life, shouldn't we measure more than pounds lost?

    Whether you're currently taking a GLP-1 medication, considering treatment, living with obesity, or working in healthcare, this conversation offers a broader perspective on what meaningful treatment success can look like.

    Hosted by Mike Donnelly-Boylen and Zach Niemiec, Weight & Measure translates obesity science for the people living it.

    We explore obesity medicine, GLP-1 and other obesity management medications, metabolic & bariatric surgery, nutrition, physical activity, and patient advocacy through evidence-based conversations with researchers, clinicians, and people with lived experience.

    More science. Less stigma.

    Subscribe to Weight & Measure on YouTube:
    https://www.youtube.com/@WeightandMeasurePodcast

    Find all our episodes and listening platforms:
    https://weightandmeasurepod.com

    Spotify:
    https://open.spotify.com/show/45vJYXZC0ciTNpfwoc9CVI

    Apple Podcasts:
    https://podcasts.apple.com/us/podcast/weight-measure/id1886848263

    Amazon Music:
    https://music.amazon.com/podcasts/183597e3-d4de-4d93-a7c0-55f0cc6018bd/weight-measure

    What does successful obesity treatment mean to you beyond weight loss?

    Have improvements in your strength, mobility, health, or quality of life changed how you measure your progress?

    Share your perspective in the comments. We want to hear from you.

    #GLP1 #WeightLoss #ObesityMedicine

    Disclaimer: This episode is intended for educational purposes and does not replace individualized medical advice. Medication and treatment decisions should be made with a qualified healthcare professional.

    Show More Show Less
    1 hr and 10 mins
  • Why Nutrition Matters in Obesity Care | FNCE 2026
    Oct 26 2026

    Weight & Measure with Mike and Zach | FNCE 2026 Special Coverage

    In this Short:

    What happens when patients are prescribed GLP-1 medications without meaningful nutrition guidance? And how can registered dietitians help bridge the gap between medical treatment and long-term success?

    Recorded live at the 2026 Food & Nutrition Conference & Expo (FNCE) in San Antonio, Mike and Zach sit down with Caroline Susie, RDN, LD, national spokesperson for the Academy of Nutrition and Dietetics, to discuss the evolving role of nutrition professionals in obesity care.

    From supporting patients taking GLP-1 medications to addressing weight stigma in healthcare, Caroline explains why registered dietitians are essential members of the multidisciplinary care team—and why evidence-based nutrition guidance matters more than ever.

    The conversation also explores how telehealth is improving access to nutrition care, why language matters when discussing obesity, and how patients can advocate for more comprehensive support.

    • Beyond the prescription: Why GLP-1 medications should be accompanied by individualized nutrition support.

    • Nutrition and patient safety: The importance of adequate protein, fiber, preventing nutrient deficiencies, and managing medication side effects.

    • Addressing weight stigma: How language, provider education, and compassionate care can improve the patient experience.

    • Expanding access: How telehealth and registered dietitians can help patients receive support wherever they live.

    • Separating science from misinformation: Why credentials and evidence-based guidance matter in an increasingly crowded nutrition information landscape.

    Resources:

    Academy of Nutrition and Dietetics: eatright.org

    Food & Nutrition Conference & Expo: eatrightfnce.org

    Weight & Measure with Mike and Zach translates obesity science into accessible, meaningful conversations for the people living it. Through expert perspectives and lived experience, we explore obesity medicine, GLP-1 therapies, metabolic and bariatric surgery, and the evolving science of obesity care.

    More science. Less stigma.

    #FNCE2026 #WeightAndMeasure #ObesityMedicine #GLP1 #RegisteredDietitian #NutritionScience #ObesityCare

    Show More Show Less
    12 mins
  • Before Bariatric Surgery or GLP-1s: Mental Health & Nutrition
    Oct 19 2026

    Thinking about starting a GLP-1 medication or having bariatric surgery? What should you know about your mental health, nutritional deficiencies, emotional eating, and relationship with food before treatment begins?

    Whether you're considering Wegovy, Zepbound, gastric sleeve surgery, or gastric bypass, preparing for obesity treatment involves more than understanding weight loss and physical side effects.

    In this episode of Weight & Measure with Mike and Zach, hosts Mike Donnelly-Boylen and Zach Niemiec welcome Dr. Lillian Craggs-Dino, registered dietitian, and Dr. Nini Peterson, clinical and health psychologist, to explore the psychological and nutritional considerations before starting an obesity management medication (OMM) or undergoing metabolic & bariatric surgery.

    Mental Health & Psychological Evaluations: Why psychological evaluations before bariatric surgery aren't simply pass-or-fail tests, how depression and anxiety fit into treatment planning, and why mental health support should help patients access appropriate care rather than create unnecessary barriers.

    Vitamin Deficiencies & Mental Health: How deficiencies involving thiamine (vitamin B1), vitamin B12, other B vitamins, and copper may affect neurological and psychological health, and why nutritional screening and monitoring are important.

    Food Noise & Emotional Eating: How GLP-1 medications and bariatric surgery can change hunger, appetite, coping mechanisms, body image, and relationships with food.

    The MIND Diet & Brain Health: What the MIND diet is, what research suggests about nutrition and cognitive health, and how its principles may fit into obesity treatment.

    Family Support & Long-Term Care: Why loved ones shouldn't become the "food police" and why multidisciplinary support from dietitians, behavioral health professionals, and other members of the care team matters.

    • How should I prepare mentally for bariatric surgery or GLP-1 treatment?

    • What happens during a bariatric psychological evaluation?

    • Can vitamin deficiencies affect mood, energy, or cognitive health?

    • Do I need to address emotional eating before starting treatment?

    • What is the MIND diet, and how does nutrition relate to brain health?

    • How can family members provide meaningful support?

    Preparing for obesity treatment isn't about becoming a perfect patient. It's about having the right support.

    Patients deserve evidence-based, compassionate care that supports their nutritional, physical, and psychological well-being before and after treatment.

    Help us reach 1,000 YouTube subscribers! Subscribe, follow, and share this episode with someone considering obesity treatment.

    YouTube: https://www.youtube.com/@WeightandMeasurePodcast

    Spotify: https://open.spotify.com/show/45vJYXZC0ciTNpfwoc9CVI

    Apple Podcasts: https://podcasts.apple.com/us/podcast/weight-measure/id1886848263

    Website: https://weightandmeasurepod.com

    More Science. Less Stigma.

    This episode is educational and does not replace individualized medical, nutritional, or mental health advice.

    #BariatricSurgery #GLP1 #MentalHealth #ObesityMedicine #WeightAndMeasure

    Show More Show Less
    1 hr and 11 mins
  • What Does Your Gut Microbiome Have to Do With Obesity, GLP-1s & Bariatric Surgery?
    Oct 12 2026

    What Does Your Gut Microbiome Have to Do With Obesity, GLP-1s & Bariatric Surgery?

    Can your gut microbiome affect obesity, weight loss, GLP-1 medications, or metabolic & bariatric surgery outcomes? And can what you eat actually change how many calories your body absorbs?

    In this episode of Weight & Measure with Mike and Zach, we sit down with Karen D. Corbin, PhD, RD, Associate Investigator at AdventHealth Translational Research Institute, for a deep dive into the rapidly evolving science of the gut microbiome, obesity, metabolism, GLP-1 based medications, and metabolic & bariatric surgery.

    Dr. Corbin starts with the basics: What is the gut microbiome? Is there actually such a thing as “good” and “bad” gut bacteria? What makes a microbiome healthy? And how do diet, fiber, resistant starch, genetics, hormones, environment, and medications shape the trillions of microorganisms living in our gut?

    Then we get into the obesity science.

    Dr. Corbin explains research examining how the gut microbiome may influence energy balance and calorie absorption, including her team's controlled feeding study comparing a Western diet with a “microbiome enhancer diet.” Participants eating the microbiome-focused diet absorbed, on average, 116 fewer calories per day, with some individuals showing substantially larger differences in unabsorbed energy.

    We also explore the questions many people using obesity treatments are asking:

    Does your gut microbiome change when you take a GLP-1 medication? Could your microbiome influence how well a GLP-1 works? Why do two people taking the same medication sometimes experience different weight-loss responses? What happens to the microbiome after sleeve gastrectomy, gastric bypass, or other metabolic & bariatric surgery?

    Dr. Corbin explains why much of the research connecting GLP-1 medications and the microbiome still comes from animal models, what scientists need to demonstrate in humans, and why separating the effects of medication, weight loss, diet, GI transit, and metabolic improvements is so difficult.

    We also tackle the idea of “GLP-1 receptor sensitivity.” Is GLP-1 resistance actually an established phenomenon? Could genetic differences in the GLP-1 receptor affect treatment response? And have supplements and gut-health products gotten ahead of the science by adding “GLP-1” to their marketing?

    Plus, Dr. Corbin busts a major probiotic myth and explains why adding a handful of bacterial species isn't the same thing as rebuilding an incredibly complex microbial ecosystem.

    • What the gut microbiome actually is
    • “Good” vs. “bad” gut bacteria
    • What makes a healthy microbiome
    • How food and nutrition shape gut bacteria
    • Fiber, resistant starch, whole foods, and ultra-processed foods
    • The gut-brain axis, hunger, satiety, and naturally produced GLP-1
    • Gut bacteria, calorie absorption, and energy balance
    • The microbiome and obesity
    • GLP-1 medications and gut microbiome changes
    • Why GLP-1 response varies between people
    • GLP-1 receptor sensitivity and genetics
    • The microbiome after metabolic & bariatric surgery
    • Sleeve gastrectomy and gastric bypass
    • Probiotics and microbiome myths
    • What gut-health science can and cannot tell us today
    • How to support your microbiome with food
    • Where microbiome and obesity research goes next

    One of the most important takeaways: an association between the microbiome and a disease does not necessarily mean the microbiome caused it. The science is promising, but there is still much researchers don't understand.

    As Dr. Corbin puts it, one practical question we can ask ourselves is: “Have I fed my gut microbiome today?”

    Subscribe to Weight & Measure with Mike and Zach for evidence-based conversations about obesity, GLP-1 medications, obesity management medications (OMMs), metabolic & bariatric surgery, nutrition, metabolic health, and lived experience.

    More Science. Less Stigma.

    Show More Show Less
    1 hr and 7 mins